AzTrials
AzTrials

Cardiac SurgeryFast TrackNCT07518524

Ultra Fast-Track vs Fast-Track Protocols in Off-Pump and Minimally Invasive Valve Cardiac Surgery

A study testing Fast Track Cardiac Anesthesia (FTCA) and Ultra Fast Track Cardiac Anesthesia (UFTCA) in people with Cardiac Surgery, run by Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Fast-track cardiac anesthesia (FTCA) has gained significant popularity over the past decades due to its potential to reduce healthcare costs and optimize the use of medical resources. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Surgery
What is being tested?
Fast Track Cardiac Anesthesia (FTCA) and Ultra Fast Track Cardiac Anesthesia (UFTCA)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteItaly
Study dates
18 Jun 2025to 15 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients over 18 years of age
  • All patients scheduled for elective off-pump cardiac surgery or minimally invasive valve surgery via minithoracotomy, who provide explicit consent to participate in the protocol and sign the informed consent form.

Who cannot join

  • Patients extubated more than 6 hours postoperatively
  • Positive pregnancy test
  • Patients who, for clinical reasons, cannot be awakened in the operating room, including difficult intubation, respiratory failure with P/F ratio < 200, hemodynamic instability requiring more than one vasoactive drug, cardiopulmonary bypass duration > 150 minutes, active perioperative bleeding, core temperature < 35°C.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Trial office Trial Office contact

+39 0331449168

trialoffice@asst-ovestmi.it

Italy1 site, 1 recruiting
  • Trial Office

    Legnano, Italy, 20025

    Trial office Trial office, trialoffice@asst-ovestmi.it

    Recruiting

Other trials in Italy

About this study

Official title: Studio Randomizzato Prospettico Comparativo di Due Protocolli di Gestione Perioperatoria Per Interventi di Cardiochirurgia Off Pump e di Chirurgia Valvolare Minitoracotomica

Fast-track cardiac anesthesia (FTCA) has gained significant popularity over the past decades due to its potential to reduce healthcare costs and optimize the use of medical resources. This approach has led anesthesiologists to reconsider the traditional model of cardiac anesthesia, known as Conventional Cardiac Anesthesia (CCA), which historically relied on the administration of high-dose opioids to ensure adequate hemodynamic stability and prolonged postoperative analgesia, thereby reducing the incidence of myocardial ischemia.

One of the primary goals of fast-track cardiac anesthesia is early tracheal extubation. Increasing evidence demonstrates that early extubation is associated with a reduction in the length of stay in the intensive care unit (ICU) and overall hospital length of stay, resulting in significant cost savings without negatively affecting patients' clinical outcomes. In contrast, prolonged mechanical ventilation has been shown to have a substantial economic impact and, more importantly, is associated with higher in-hospital mortality and reduced long-term survival, including decreased five-year survival rates. The Ultra Fast Track protocol, which involves extubation directly in the operating room, is currently less commonly used. However, it may further reduce postoperative mechanical ventilation time and the incidence of pulmonary complications, potentially leading to an additional reduction in hospital length of stay. The aim of this study is to compare the Fast Track and Ultra Fast Track protocols in order to evaluate differences in the incidence of respiratory, cardiac, renal, septic, and neurological complications. Postoperative pain will also be assessed using the Numeric Rating Scale (NRS), as well as the incidence of postoperative nausea and vomiting (PONV).

Conditions
Cardiac Surgery
Being tested
Fast Track Cardiac Anesthesia (FTCA), Ultra Fast Track Cardiac Anesthesia (UFTCA)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fast Track Cardiac Anesthesia (FTCA)Procedure or surgery

    Balanced general anesthesia with early extubation within 6 hours after surgery, followed by standard postoperative monitoring and care in the intensive care unit according to institutional practice.

  • Ultra Fast Track Cardiac Anesthesia (UFTCA)Procedure or surgery

    Tracheal extubation in the operating room immediately after completion of surgery, followed by postoperative monitoring and care according to standard institutional practice.

Study groups in NCT07518524
Study groupRoleWhat they receive
Fast track cardiac anesthesia (FTCA)Active comparatorParticipants undergoing cardiac surgery via minithoracotomy receive a Fast Track Cardiac Anesthesia (FTCA) protocol.
Receives: Procedure: Fast Track Cardiac Anesthesia (FTCA)
Ultra Fast Track cardiac anesthesia (UFTCA)Active comparatorParticipants undergoing cardiac surgery via minithoracotomy receive an Ultra Fast Track Cardiac Anesthesia (UFTCA) protocol, with the goal of tracheal extubation in the operating room immediately after completion of surgery, followed by postoperative monitoring and care according to standard institutional practice.
Receives: Procedure: Ultra Fast Track Cardiac Anesthesia (UFTCA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of postoperative pulmonary complications

    Incidence of postoperative pulmonary complications (PPCs), defined as a composite outcome including pneumonia, pleural effusion, atelectasis, or pneumothorax, within 7 days after ICU discharge or before hospital discharge (whichever occurs first), according to European Perioperative Clinical Outcome (EPCO) definitions.

    Unit of Measure: Percentage of participants with at least one PPC.

    Measured: From ICU discharge to Day 7 post-discharge

Secondary outcomes (6)
  1. Efficacy and safety on postoperative recovery

    Incidence of postoperative delirium assessed using the Confusion Assessment Method for the ICU (CAM-ICU) on postoperative day 0 and day 1.

    Unit of Measure: Percentage of events in the observation window.

    Measured: From ICU discharge to Day 7 post-discharge

  2. Efficacy and safety on postoperative recovery

    Incidence of cardiovascular complications, defined as a composite outcome including heart failure, myocardial ischemia, atrial fibrillation, or renal failure.

    Unit of Measure: Percentage of events in the observation window.

    Measured: From ICU discharge to Day 7 post-discharge

  3. Efficacy and safety on postoperative recovery

    Incidence of neurological complications, defined as a composite outcome including transient ischemic attack (TIA) or stroke.

    Unit of Measure: Percentage of events in the observation window.

    Measured: From ICU discharge to Day 7 post-discharge

  4. Efficacy and safety on postoperative recovery

    Incidence of septic complications, defined as a composite outcome including infection, sepsis, or septic shock.

    Unit of Measure: Percentage of events in the observation window.

    Measured: From ICU discharge to Day 7 post-discharge

  5. Efficacy and safety on postoperative recovery

    Length of stay in the intensive care unit (ICU) and length of hospital stay. Unit of Measure: Days

    Measured: From date of surgery until hospital discharge, up to 30 days

  6. Efficacy and safety on postoperative recovery

    Duration of endotracheal intubation. Unit of Measure: Hours

    Measured: From endotracheal intubation to extubation, up to 48 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2026
  2. Study start18 Jun 2025
  3. Primary completion1 Mar 2026
  4. Study completion15 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07518524
Sponsor's protocol ID
13-2025
Other IDs
5925
Acronym
Fast Track
Status last verified
Mar 2026
First submitted
10 Mar 2026
Last updated
8 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Fast Track Cardiac Anesthesia (FTCA) and Ultra Fast Track Cardiac Anesthesia (UFTCA) in people with Cardiac Surgery, run by Azienda Socio Sanitaria Territoriale Ovest Milanese, Ospedale di Legnano at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Trial office Trial Office (+39 0331449168, trialoffice@asst-ovestmi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of postoperative pulmonary complications (time frame: From ICU discharge to Day 7 post-discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Fast Track Clinical Trial NCT07518524 | AzTrials